Pharmacological therapies for the treatment of osteoarthritis.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S108, doi. 10.5694/j.1326-5377.2001.tb143845.x
- By:
- Publication type:
- Article
Works matching IS 0025729X AND DT 2001 AND VI 175
Results: 200
1
2
Non‐pharmacological approaches to managing arthritis.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S102, doi. 10.5694/j.1326-5377.2001.tb143844.x
- By:
- Publication type:
- Article
3
The role of the rheumatologist in managing arthritis.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S97, doi. 10.5694/j.1326-5377.2001.tb143843.x
- By:
- Publication type:
- Article
4
Managing osteoarthritis in general practice: a long‐term approach.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S92, doi. 10.5694/j.1326-5377.2001.tb143842.x
- By:
- Publication type:
- Article
5
Managing arthritis in the Bone and Joint Decade.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S91, doi. 10.5694/j.1326-5377.2001.tb143841.x
- By:
- Publication type:
- Article
6
11. References.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S84, doi. 10.5694/j.1326-5377.2001.tb143840.x
- Publication type:
- Article
7
Adherence to the pharmacological management of dyslipidaemia.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S83, doi. 10.5694/j.1326-5377.2001.tb143839.x
- Publication type:
- Article
8
Recommendations for using lipid‐modifying drugs.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S82, doi. 10.5694/j.1326-5377.2001.tb143838.x
- Publication type:
- Article
9
Cholesterol levels in the general population.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S81, doi. 10.5694/j.1326-5377.2001.tb143837.x
- Publication type:
- Article
10
Management and follow‐up after absolute risk is determined.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S81, doi. 10.5694/j.1326-5377.2001.tb143836.x
- Publication type:
- Article
11
Frequency of lipid testing for adults.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S81, doi. 10.5694/j.1326-5377.2001.tb143835.x
- Publication type:
- Article
12
What should be measured?
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S80, doi. 10.5694/j.1326-5377.2001.tb143834.x
- Publication type:
- Article
13
Lifestyle interventions for the management of abnormal plasma lipid levels and cardiovascular disease risk.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S79, doi. 10.5694/j.1326-5377.2001.tb143833.x
- Publication type:
- Article
14
10. Overall recommendations.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S79, doi. 10.5694/j.1326-5377.2001.tb143832.x
- Publication type:
- Article
15
Surrogates for atherosclerosis.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S79, doi. 10.5694/j.1326-5377.2001.tb143831.x
- Publication type:
- Article
16
Screening for plasma lipid levels.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S78, doi. 10.5694/j.1326-5377.2001.tb143830.x
- Publication type:
- Article
17
Other predictors of risk and possible targets for therapy.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S78, doi. 10.5694/j.1326-5377.2001.tb143829.x
- Publication type:
- Article
18
What should be the target levels for triglyceride and high‐density lipoprotein cholesterol?
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S78, doi. 10.5694/j.1326-5377.2001.tb143828.x
- Publication type:
- Article
19
What should the target low‐density lipoprotein cholesterol concentration be?
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S78, doi. 10.5694/j.1326-5377.2001.tb143827.x
- Publication type:
- Article
20
Choice of lipid‐modifying agents.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S78, doi. 10.5694/j.1326-5377.2001.tb143826.x
- Publication type:
- Article
21
Special groups.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S77, doi. 10.5694/j.1326-5377.2001.tb143825.x
- Publication type:
- Article
22
9. Areas of uncertainty.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S77, doi. 10.5694/j.1326-5377.2001.tb143824.x
- Publication type:
- Article
23
Maximising adherence.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S77, doi. 10.5694/j.1326-5377.2001.tb143823.x
- Publication type:
- Article
24
The Australian studies.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S76, doi. 10.5694/j.1326-5377.2001.tb143822.x
- Publication type:
- Article
25
8. Adherence to the pharmacological management of dyslipidaemia.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S76, doi. 10.5694/j.1326-5377.2001.tb143821.x
- Publication type:
- Article
26
7. Safety of lipid‐modifying drugs.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S76, doi. 10.5694/j.1326-5377.2001.tb143820.x
- Publication type:
- Article
27
Influence and implications of sex differences.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S76, doi. 10.5694/j.1326-5377.2001.tb143819.x
- Publication type:
- Article
28
Definition of higher coronary heart disease risk for the purposes of guiding lipid‐modifying medication.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S75, doi. 10.5694/j.1326-5377.2001.tb143818.x
- Publication type:
- Article
29
6. Risk issues: who should receive lipid‐modifying therapy?
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S75, doi. 10.5694/j.1326-5377.2001.tb143817.x
- Publication type:
- Article
30
Other lifestyle factors.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S74, doi. 10.5694/j.1326-5377.2001.tb143816.x
- Publication type:
- Article
31
Tobacco smoking.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S74, doi. 10.5694/j.1326-5377.2001.tb143815.x
- Publication type:
- Article
32
Physical activity and exercise.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S74, doi. 10.5694/j.1326-5377.2001.tb143814.x
- Publication type:
- Article
33
Nutrients and eating patterns.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S73, doi. 10.5694/j.1326-5377.2001.tb143813.x
- Publication type:
- Article
34
Prospective studies of lifestyle patterns.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S73, doi. 10.5694/j.1326-5377.2001.tb143812.x
- Publication type:
- Article
35
Conclusions on the relationship between plasma lipid levels and vascular disease in renal disease.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S73, doi. 10.5694/j.1326-5377.2001.tb143811.x
- Publication type:
- Article
36
Chronic renal failure.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S72, doi. 10.5694/j.1326-5377.2001.tb143810.x
- Publication type:
- Article
37
Conclusions on relationship between plasma lipid levels and vascular disease in diabetes.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S72, doi. 10.5694/j.1326-5377.2001.tb143809.x
- Publication type:
- Article
38
Diabetes.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S72, doi. 10.5694/j.1326-5377.2001.tb143808.x
- Publication type:
- Article
39
Conclusions on the relationship between plasma lipids and stroke.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S71, doi. 10.5694/j.1326-5377.2001.tb143807.x
- Publication type:
- Article
40
Stroke in secondary prevention trials in coronary heart disease patients.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S71, doi. 10.5694/j.1326-5377.2001.tb143806.x
- Publication type:
- Article
41
Stroke in primary prevention trials.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S71, doi. 10.5694/j.1326-5377.2001.tb143805.x
- Publication type:
- Article
42
Population studies relating cholesterol and stroke.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S71, doi. 10.5694/j.1326-5377.2001.tb143804.x
- Publication type:
- Article
43
Conclusions from the trials of triglyceride lowering and high‐density lipoprotein cholesterol raising.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S71, doi. 10.5694/j.1326-5377.2001.tb143803.x
- Publication type:
- Article
44
Studies with statins.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S70, doi. 10.5694/j.1326-5377.2001.tb143802.x
- Publication type:
- Article
45
Human intervention studies with fibrates.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S69, doi. 10.5694/j.1326-5377.2001.tb143801.x
- Publication type:
- Article
46
Prospective human population studies.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S68, doi. 10.5694/j.1326-5377.2001.tb143800.x
- Publication type:
- Article
47
Biological mechanism relating triglyceride and high‐density lipoproteins to coronary heart disease.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S68, doi. 10.5694/j.1326-5377.2001.tb143799.x
- Publication type:
- Article
48
2. Plasma triglyceride and high density lipoprotein cholesterol.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S68, doi. 10.5694/j.1326-5377.2001.tb143798.x
- Publication type:
- Article
49
Criteria for inclusion of studies.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S65, doi. 10.5694/j.1326-5377.2001.tb143797.x
- Publication type:
- Article
50
Intervention studies.
- Published in:
- Medical Journal of Australia, 2001, v. 175, p. S65, doi. 10.5694/j.1326-5377.2001.tb143796.x
- Publication type:
- Article